My Web Dashboard





SEO News: ZymoGenetics And Serono Report Detailed Positive Results From Atacicept Phase 1b Clinical Trial In Patients With Lupus (Medical News Today)

ZymoGenetics, Inc. (Nasdaq: ZGEN) and Serono (virt-x: SEO and NYSE: SRA) today presented positive results at the American College of Rheumatology (ACR) annual meeting from a Phase 1b study in systemic lupus erythematosus (SLE) patients treated with atacicept(1). The results showed that atacicept was well tolerated across all dose levels and schedules in the study. [click link for full article]

read more...

Related News